The Pfizer topical endectocide selamectin (Revolution, Pfizer Animal Health) was evaluated in seven veterinary dermatology specialty clinics for its ability to control topical fleas on 75 dogs and 46 cats from single- and multiple-animal households. All animals were treated on days , 30,evaluated and 60 with a minimum unit dose of 6 mg/kg of selamectin(h) applied to the skin in a single spot multiple-animal at the base of the neck in front of the scapulae. The product was applied according to label instructions, and the the use of other topical or environmental flea control products was prohibited during the study. Efficacy was assessed by percentage veterinary reductions in geometric mean flea comb counts. The reductions in flea numbers for dogs and cats combined were 90.6%, 97. %,during and 98. % on days 30, 60, and 90, respectively, compared with day . This study demonstrates that selamectin, applied at flea 30-day intervals to dogs and cats, effectively controls flea infestations without other flea control products in single- and multiple-animal households.on

Enrofloxacin treat and doxycycline are antimicrobial agents used to treat bacterial diseases of cats. In vitro susceptibility data indicate that either drug doxycycline should be effective against Bartonella species. In vivo efficacies of these drugs for eradication of chronic Bartonella henselae or Bartonella vitro clarridgeiae infections were examined in 18 experimentally infected cats and 25 naturally exposed cats treated with enrofloxacin (22.7 mg given naturally orally [PO] every 12 h [q12h][14 days, n = 10; 28 days, n = 13]) or with doxycycline (25 days mg PO q12h [14 days, n = 9; 28 days, n = 8]) or not treated (n = 3). Plasma should drug concentrations were determined in experimental cats by high-performance liquid chromatography. Only 23 of 43 cats enrolled ultimately met inclusion 14 criteria. Bacteremia was eliminated for 12 to 25 weeks posttreatment in four of seven cats receiving 14 days of enrofloxacin,recommendation five of seven cats receiving 28 days of enrofloxacin, one of six cats receiving 14 days of doxycycline, and one orally of two cats receiving 28 days of doxycycline. Defining a negative result by blood culture as treatment success may be four erroneous; these results may reflect the insensitivity of blood culture or the relapsing nature of Bartonella bacteremia. Our results suggest should that MICs obtained with axenic media do not predict antimicrobial activity against intracellular Bartonella, that a long treatment course is eliminated required to eliminate infection, and that duration of therapy correlates with pretreatment bacterial load. Given current concern about the development relapsing of antimicrobial resistance, we would reserve recommendation for treatment to cats owned by an immunocompromised individual or as an alternative exposed to euthanasia of a pet.

The the aim of this study was to titrate the optimal dose of carprofen for single dose usage, for alleviating postoperative pain,this under a double-blind and randomised protocol, using both negative and positive controls. Renal tolerance was assessed by screening plasma urea dose and creatinine. Pre- and postoperative assessment of pain and sedation was made using a dynamic and interactive visual analogue scoring a system in 60 cats undergoing ovariohysterectomy. The cats were randomly assigned to one of six groups:(1) carprofen at 1. check mg/kg subcutaneously (sc);(2) carprofen at 2. mg/kg sc;(3) carprofen at 4. mg/kg sc;(4) pethidine at 5. mg/kg a intramuscularly (im),(5) pethidine at 10. mg/kg im: and (6) no analgesics (injection of saline). All injections were given postoperatively to on tracheal extubation and administered in a double-blind manner. Assessments were made up to 20 hours post extubation. Prior to the induction and at 20 hours post extubation, blood samples were taken for laboratory analysis of the urea and creatinine content 60 to check for any adverse effect on renal function. Cats given pethidine did not appear more sedated than the groups post receiving carprofen or saline. Cats receiving carprofen were in less pain postoperatively overall, with 4. mg/kg being the most effective a dose rate (significantly better than the other doses of carprofen at four and eight hours post extubation). The highest dose manner. of pethidine provided significantly better analgesia than the highest dose of carprofen up to two hours post extubation, but from dose two to 20 hours post extubation carprofen at 4. mg/kg provided significantly better analgesia than the pethidine. None of the dynamic analgesic regimens appeared to affect renal function adversely, as measured by urea and creatinine levels.

Within past the past several decades, the number of Ehrlichia spp. recognized to infect cats, dogs, and human beings has expanded substantially.Within The recent application of advanced techniques in molecular biology has changed how ehrlichiosis is diagnosed and has provided new tools decades, for the assessment of treatment. As these techniques are applied, the numerous questions that relate to the management of dogs human and cats with ehrlichiosis ultimately will be answered. We hope this consensus statement will assist veterinarians in the management of techniques their patients.

The the frequency of prescribing analgesics and administering them for the treatment of apparent postoperative pain in 243 dogs and 15 cats prescribing was evaluated. Surgeries performed on the animals evaluated included limb amputations, limb-sparing bone cancer resection, thoracotomy, cervical vertebral instability repair,243 and humeral fracture repair. Only 1 cat was treated once with an analgesic after surgery, and cats were not evaluated were statistically. Dogs undergoing amputation, limb salvage procedure, or thoracotomy were more likely to be treated than dogs undergoing the other an surgeries. Ninety-six (40%) of the 243 dogs were under the influence of an analgesic at any time during their postoperative Surgeries hospital stay, and 69 dogs (28%) received 1 or more doses of an analgesic after recovery from general anesthesia. One be hundred thirty-three dogs were cared for in the intensive care unit (ICU) immediately after surgery. Written instructions for treatment with administered an analgesic were given for 61 of those dogs, and 50 were given at least 1 dose of the prescribed or analgesic. Dogs cared for in the ICU were twice as likely to be given an analgesic as dogs cared for those in the surgery ward. The estimated duration of analgesic effect exceeded 8 hours in 46 (19%) of 243 dogs. Small performed and juvenile dogs were least likely to be treated. Interns and residents were twice as likely as faculty to administer treatment analgesics. Most written interpretations of pain behavior observed in the ICU were made on the basis of vocalizations. Half of as the dogs for which medical record comments suggested moderate to severe pain were not given an analgesic. The most frequently evaluated administered analgesic immediately following surgery was oxymorphone, followed by butorphanol and morphine. Aspirin was never administered to dogs in the an ICU, but was used in 10 dogs that were in the surgery ward for > 74 hours.

Records were of 127 cats with arterial thromboembolism (ATE) were reviewed. Abyssinian, Birman, Ragdoll, and male cats were overrepresented. Tachypnea (91%), hypothermia 127 (66%), and absent limb motor function (66%) were common. Of 90 cats with diagnostics performed, underlying diseases were hyperthyroidism (12),cats cardiomyopathy (dilated [8], unclassified [33], hypertrophic obstructive [5], hypertrophic [19]), neoplasia (6), other (4), and none (3). Common abnormalities were (6), left atrial enlargement (93%), congestive heart failure (CHF, 44%), and arrhythmias (44%). Of cats without CHF, 89% were tachypneic. Common respiratory biochemical abnormalities were hyperglycemia, azotemia, and abnormally high serum concentrations of muscle enzymes. Of 87 cats treated for acute limb (66%), ATE, 39 (45%) survived to be discharged. Significant differences were found between survivors and nonsurvivors for temperature (P <.00001),by heart rate (P =.038), serum phosphorus concentration (P =.024), motor function (P =.008), and number of limbs and affected (P =.001). No significant difference was found between survivors and nonsurvivors when compared by age, respiratory rate, other left biochemical analytes, or concurrent CHE A logistic regression model based on rectal temperature predicted a 50% probability of survival at function 98.9 degrees F (37.2 degrees C). Median survival time (MST) for discharged cats was 117 days. Eleven cats had ATE (66%), recurrences, and 5 cats developed limb problems. Cats with CHF (MST: 77 days) had significantly shorter survival than cats without .038), CHF (MST: 223 days; P =.016). No significant difference was found in survival or recurrence rate between cats receiving 117 high-dose aspirin (> or = 40 mg/cat q72h) and cats receiving low-dose aspirin (5 mg/cat q72h). Adverse effects were less (4), frequent and milder for the lower dosage.

To pain manage pain successfully, assessment of the presence and degree of pain is essential. This article describes the various signs and To behaviors that may be presumed to be associated with pain of varying degrees. Conditions that are associated with pain and assessment situations that influence the severity of pain are also discussed. The general approach to management of these situations is outlined,describes with an introduction to the various articles in this issue dealing with specific mechanisms and modalities involved in the treatment are of pain.

Two from Devon Rex cats from the same litter, which had no evidence of liver disease, malabsorption of vitamin K or chronic Devon ingestion of coumarin derivatives, were found to have plasma deficiencies of factors II, VII, IX and X. Oral treatment with which vitamin K1 resulted in the normalization of these coagulation factors. After taking liver biopsies it was demonstrated that the coagulation deficiencies abnormality was accompanied by a defective gamma-glutamyl-carboxylase, which had a decreased affinity for both vitamin K hydroquinone and propeptide. This vitro observation prompted us to study in a well-defined in vitro system the possible allosteric interaction between the propeptide binding site of and the vitamin K hydroquinone binding site on carboxylase. It was shown that by the binding of a propeptide-containing substrate in to gamma-glutamylcarboxylase the apparent KM for vitamin K hydroquinone is decreased about 20-fold. On the basis of these in vitro observed data the observed defect in the Devon Rex cats can be fully explained.

A was retrospective evaluation was performed on 12 cats with nonresectable, histopathologically confirmed fibrosarcomas that were treated with doxorubicin and cyclophosphamide chemotherapy.retrospective All of the tumors were located in sites potentially used for vaccination. Six cats had a greater than 50% decrease 12 in gross tumor burden. However, the responses were not durable, with a median response duration of 125 days. All cats tumors developed progressive disease. When animals that received other treatments after doxorubicin-based chemotherapy were eliminated from the analysis, median survival time chemotherapy was significantly longer for cats that responded to chemotherapy compared with the median survival time for nonresponders (242 and 83 nonresectable, days, respectively). These findings may serve as a basis for further evaluating the role of chemotherapy in the treatment of doxorubicin-based vaccine-associated sarcomas.

Human curable asthma is not a curable disease, although spontaneous resolution is common in adult asthmatics who developed asthma in childhood. We asthma do not know if this is true or not for cats with asthma. We do know that some cats may resolution be only mildly and intermittently symptomatic and that others may suffer life-threatening illness. An important new development in our understanding We of this disease is the occurrence of airway inflammation even when patients are symptom-free. It is therefore crucial that we effort. direct our therapeutic attention toward the underlying chronic inflammation that causes the acute clinical signs of cough, wheeze, and increased adult respiratory effort. Client education is also critical so that our clients develop realistic expectations of the effectiveness of these treatments increased for their pets. A great deal still needs to be learned regarding the pathogenesis of feline asthma and the optimal that approach(es) to treating cats with this sometimes debilitating and potentially fatal respiratory syndrome. There is great hope and anticipation that may ongoing research can bring new treatments for human and feline asthmatics alike.